Leticia has over 25 years of industry experience managing several research projects and clinical studies in various roles. She started her career at Biogen, working collaboratively in an integrated monoclonal antibody research team and then moving to development in clinical operations, where she managed numerous phase I-III clinical trials with Avonex, Tysabri and Tecfidera in diverse therapeutic areas including, gastroenterology, immunology, neurology, and neuropathic pain. She continued her career at Merck/EMD Serono where she provided strategic and operational expertise in the planning and conduct of several phase III clinical studies with Rebif and Mavenclad in neurology, and with Bavencio in immuno-oncology, which was approved in merkel cell carcinoma and in urothelial carcinoma. Later she served as a Chief of Staff to senior leadership, where she partnered with executive sponsors to identify and promote projects that are of strategic importance to the company and translating the function strategy into operational plans. After many years in big pharma, Leticia continued her career at various start-up biotech companies: first at Kiniksa Pharmaceuticals, where she was responsible for various programs with high complexity in rare diseases, consisting of numerous global clinical trials in 10 different indications. Followed by Black Diamond Therapeutics, a biotech company addressing the significant unmet need for novel precision oncology therapies for patients with genetically defined cancers. Following that, Leticia provided consultancy services for Nimbus Therapeutics, a biotechnology company who uses cutting-edge tools to make therapeutic progress against the most challenging of targets. Currently Leticia serves as the Vice-President of Global Clinical Operations at Brainstorm Cell Therapeutics, a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases. Leticia also serves as an IRB Member at Yale University, she sits on the Advisory Board of Leal Health, an AI-powered decision-making support platform dedicated to expediting patient access to all available advanced cancer treatments and is the Chair and President of the New England Chapter of the Association of Clinical Research Professionals (ACRP). Leticia earned her Bachelor’s degree in Biomedical Laboratory and Clinical Sciences from the School of Medicine at Boston University, followed by a Master’s degree in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston.